Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

American Renal Associates (ARA)

American Renal Associates (ARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 319,453
  • Shares Outstanding, K 32,564
  • Annual Sales, $ 805,780 K
  • Annual Income, $ -28,770 K
  • 60-Month Beta 2.01
  • Price/Sales 0.43
  • Price/Cash Flow 5.37
  • Price/Book 3.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.20
  • Growth Rate Est. (year over year) +499,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.89 +66.55%
on 08/27/19
13.80 -28.91%
on 09/11/19
+2.59 (+35.87%)
since 08/13/19
3-Month
5.89 +66.55%
on 08/27/19
13.80 -28.91%
on 09/11/19
+3.58 (+57.46%)
since 06/13/19
52-Week
5.48 +79.01%
on 04/17/19
23.49 -58.24%
on 10/01/18
-10.18 (-50.93%)
since 09/13/18

Most Recent Stories

More News
American Renal Associates Holdings, Inc. Completes Restatement of Prior Financial Statements

--Provides 2019 Outlook and Preliminary 2020 Outlook

ARA : 9.81 (-7.54%)
Shareholder Alert: Robbins Arroyo LLP Reminds Investors American Renal Associates Holdings, Inc. (ARA) was Sued for Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of American Renal Associates Holdings, Inc. (NYSE: ARA) filed a class action complaint against the company for alleged...

ARA : 9.81 (-7.54%)
TXT : 51.40 (+1.00%)
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett, Molson Coors, AxoGen, and American Renal Associates and Encourages Investors to Contact the Firm

Bragar Eagel & Squire is investigating certain officers and directors of Lannett Company, Inc. (NYSE: LCI), Molson Coors Brewing Company (NYSE: TAP), AxoGen, Inc. (NASDAQ: AXGN), and American Renal Associates...

AXGN : 14.35 (+0.42%)
ARA : 9.81 (-7.54%)
TAP : 57.17 (+1.64%)
LCI : 13.95 (+0.43%)
NYSE: ARA Investor Notice: Lawsuit against American Renal Associates Holdings, Inc. announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in American Renal Associates Holdings, Inc. (NYSE: ARA) shares.

ARA : 9.81 (-7.54%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of American Renal Associates Holdings, Inc.- ARA

Levi & Korsinsky announces it has commenced an investigation of American Renal Associates Holdings, Inc.- (NYSE: ARA) concerning possible breaches of fiduciary duty. To obtain additional information, go...

ARA : 9.81 (-7.54%)
Shareholder Alert: Robbins Arroyo LLP: Another Complaint Alleges that American Renal Associates Holdings, Inc. (ARA) Misled Shareholders

Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of American Renal Associates Holdings, Inc. (NYSE: ARA) has filed a derivative complaint against the company's officers and directors...

ARA : 9.81 (-7.54%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of American Renal Associates Holdings, Inc.- ARA

Levi & Korsinsky announces it has commenced an investigation of American Renal Associates Holdings, Inc.- (NYSE: ARA) concerning possible breaches of fiduciary duty. To obtain additional information, go...

ARA : 9.81 (-7.54%)
American Renal Associates Holdings, Inc. Applauds the Advancing American Kidney Health Initiative

American Renal Associates Holdings, Inc. ("ARA" or the "Company"), a leading kidney care and dialysis provider focused on partnering with local nephrologists, issued the following statement regarding the...

ARA : 9.81 (-7.54%)
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of American Renal Associates, Molson Coors, and Orion Group Holdings and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of American Renal Associates, Inc., Molson Coors Brewing Company, and Orion Group Holdings. Additional...

ARA : 9.81 (-7.54%)
TAP : 57.17 (+1.64%)
ORN : 5.14 (unch)
AMERICAN RENAL 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until...

ARA : 9.81 (-7.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade ARA with:

Business Summary

American Renal Associates Holdings, Inc. is a provider of dialysis services primarily in the United States. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. American Renal Associates Holdings, Inc. is based in Beverly, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 11.57
1st Resistance Point 10.69
Last Price 9.81
1st Support Level 9.35
2nd Support Level 8.89

See More

52-Week High 23.49
Fibonacci 61.8% 16.61
Fibonacci 50% 14.48
Fibonacci 38.2% 12.36
Last Price 9.81
52-Week Low 5.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar